ArticleFrontiers in public health2022
Medicine Drug Name Detection Based Object Recognition Using Augmented Reality.
Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Augmented Reality (AR) is an innovation that empowers us in coordinating computerized data into the client's real-world space. It offers an advanced and progressive methodology for medicines, providing medication training. AR aids in surgery planning, and patient therapy discloses complex medical circumstances to patients and their family members. With accelerated upgrades in innovation, the ever-increasing number of medical records get accessible, which contain a lot of sensitive medical data, similar to medical substances and relations between them. To exploit the clinical texts in these data, it is important to separate significant data from these texts. Drugs, along with some kind of the fundamental clinical components, additionally should be perceived. Drug name recognition (DNR) tries to recognize drugs specified in unstructured clinical texts and order them into predefined classifications, which is utilized to deliver a connected 3D model inside the present reality client space. This work shows the utilization of AR to give an active and visual representation of data about medicines and their applications. The proposed method is a mobile application that uses a native camera and optical character recognition algorithm (OCR) to extract the text on the medicines. The extracted text is over and above processed using natural language processing (NLP) tools which are then used to identify the generic name and category of the drug using the dedicated DNR database. The database used for the system is scraped using various resources of medical studies and is named a medi-drug database from a development standpoint. 3D model prepared particularly for the drug is then presented in AR using ArCore. The results obtained are encouraging. The proposed method can detect the text with an average time of 0.005 s and can produce the visual representation of the output with an average time of 1.5 s.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.